Intrinsic Value of S&P & Nasdaq Contact Us

Envela Corporation ELA NYSE

NYSE • Consumer Cyclical • Luxury Goods • US • USD

SharesGrow Score
70/100
5/7 Pass
SharesGrow Intrinsic Value
$2.92
-83.4%
Analyst Price Target
$12.00
-31.6%

Envela Corporation (ELA) is a Luxury Goods company in the Consumer Cyclical sector, currently trading at $17.55. It has a SharesGrow Score of 70/100, indicating a above average investment profile with 5 out of 7 criteria passed.

SharesGrow calculates the intrinsic value of ELA = $2.92 (-83.4% from the current price, the stock appears overvalued). Analyst consensus target is ELA = $12 (-31.6% upside).

Valuation: ELA trades at a trailing Price-to-Earnings (P/E) of 30.3 (S&P 500 average ~25) with a forward Price/Earnings-to-Growth (PEG) of 0.78.

Financials: revenue is $241M, +10.9%/yr average growth. Net income is $15M, growing at +18.7%/yr. Net profit margin is 6.1% (thin). Gross margin is 22.4% (-2.1 pp trend).

Balance sheet: total debt is $20M against $67M equity (Debt-to-Equity (D/E) ratio 0.3, conservative). Current ratio is 3.5 (strong liquidity). Debt-to-assets is 20.7%. Total assets: $96M.

Analyst outlook: 2 / 2 analysts rate ELA as buy (100%) — strong consensus.

SharesGrow 7-Criteria breakdown: Value 70/100 (Pass), Growth 80/100 (Pass), Past 100/100 (Pass), Health 100/100 (Pass), Moat 28/100 (Fail), Future 64/100 (Pass), Income 45/100 (Partial).

$12.00
▼ 31.62% Downside
Average Price Target
The 12-month price target for Envela Corporation is $12.00.

ELA SharesGrow Score Overview

70/100
SharesGrow Score
Above average fundamentals
View full scorecard →
VALUE 70/100
Valuation — P/E, PEG, Forward PEG
GROWTH 80/100
Financials — average growth
PAST 100/100
strong — trend
HEALTH 100/100
Balance sheet — Debt-to-Equity (D/E) ratio, Current ratio is
MOAT 28/100
Gross margin is + market cap
FUTURE 64/100
Analyst outlook — as buy
INCOME 45/100
Net profit margin is
Scores derived from financial statements, analyst ratings, and balance sheet data.

Score Breakdown — ELA

VALUE Pass
70/100
ELA trades at a trailing Price-to-Earnings (P/E) of 30.3 (S&P 500 average ~25). Forward PEG 0.78 — Peter Lynch undervalued (≤1.0). Trailing PEG 0.71. Analyst consensus target is $12, implying -31.6% from the current price $18. Composite: Price-to-Earnings (20%) + Forward Price/Earnings-to-Growth (35%) + upside (25%) + trailing PEG (20%). ≥ 60 = Pass.
View details →
GROWTH Pass
80/100
ELA: +10.9%/yr revenue is, +18.7%/yr Net income is average growth. > 5%/yr — strong. Score: >20%/yr = 100, >10% = 80, >5% = 65, >0% = 45, < 0 = 15.
View details →
PAST Pass
100/100
ELA: 4 / 4 years profitable. strong — 100%. Score = 4 / 4 × 100. ≥ 80 = Pass.
View details →
HEALTH Pass
100/100
Balance sheet ELA: Debt-to-Equity (D/E) ratio 0.3 (conservative), Current ratio is 3.5 (strong liquidity). Debt-to-Equity < 0.5, Current Ratio > 1.5, Interest Coverage > 8x = ideal. ≥ 70 = Pass.
View details →
MOAT Fail
28/100
ELA: Gross margin is 22.4% (-2.1 pp trend), N/A market cap. Moat (0-100): margin (35%) + trend (15%) + market cap (30%) + revenue is (20%). Score 28/100. ≥ 70 = Pass.
View details →
FUTURE Pass
64/100
Analyst outlook: 2 / 2 analysts rate ELA as buy (100%). Analyst consensus target is $12 (-31.6% upside). Score: 60% buy consensus + 40% upside. ≥ 60 = Pass.
View details →
~
INCOME Partial
45/100
ELA: Net profit margin is 6.1%. thin (5-15%). Score: ≥30% = 100, ≥20% = 85, ≥15% = 70, ≥10% = 55, ≥5% = 45, ≥0% = 30, < 0 = 10.
View details →

Stock Chart & Stats

Market Data
52-Week Range5.33-18.29
Volume52.74K
Avg Volume (30D)113.52K
Market Cap$455.66M
Beta (1Y)0.16
Share Statistics
EPS (TTM)0.56
Shares Outstanding$25.98M
IPO Date1992-03-18
Employees309
CEOJohn Richardson Loftus
Financial Highlights & Ratios
Revenue (TTM)$241.02M
Gross Profit$53.92M
EBITDA$19.98M
Net Income$14.6M
Operating Income$18.11M
Total Cash$18.15M
Total Debt$19.86M
Net Debt$1.7M
Total Assets$96.02M
Price / Earnings (P/E)31.3
Price / Sales (P/S)1.89
Analyst Forecast
1Y Price Target$12.00
Target High$12.00
Target Low$12.00
Upside-31.6%
Rating ConsensusBuy
Analysts Covering2
Buy 100% Hold 0% Sell 0%
Price Target Summary
Company Info
CountryUS
ExchangeNYSE
CurrencyUSD
ISINUS29402E1029

Price Chart

ELA
Envela Corporation  ·  NYSE
Consumer Cyclical • Luxury Goods
5.33 52WK RANGE 18.29
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message